Lumibird SA — Cyborg Score 7/10

Strong
Photonics & Laser Technology Manufacturing

Strategic Profile

Lumibird was created through the merger of Quantel and Keopsys in October 2017, combining decades of French laser expertise into a vertically integrated photonics group. The company generates a majority of its revenue from scientific and industrial applications. Strategic growth is driven by defense contracts, medical acquisitions, and emerging applications in autonomous systems and LiDAR sensors.

Cyborg Score Rationale

With a market cap of $594M and trailing 12-month revenue of $238M as of mid-2025, Lumibird demonstrates solid scale and profitability. Strong positioning in high-margin defense and medical segments, combined with vertical integration of core technologies, supports operational resilience. Growth headwinds from supply chain and defense budget uncertainty create modest execution risk.

Top Insights

  • Recent acquisitive growth includes the merger with Continuum Electro Optics in October 2024, expanding defense capabilities
  • Medical division showing strong growth trajectory post-Ellex acquisition; expanding ophthalmology and ultrasound diagnostics capabilities
  • Exports above 70% with revenue rising to approximately €210-€220m in 2023, reflecting global market diversification and scaling
  • Vertical integration strategy in diodes and fiber components supports margin protection and technology control in competitive photonics markets

Named Competitors

  • Fiber lasers and amplifiers — Global leader in high-power fiber laser systems
  • Industrial and medical lasers — Broad portfolio of laser technologies for industrial, medical and defense
  • Medical/ophthalmology lasers — Vascular and orthopedic laser intervention systems
  • Pulsed solid-state lasers — European specialist in solid-state laser solutions

Recent Developments

  • (October 2024) Acquisition of Continuum Electro Optics to strengthen defense laser portfolio
  • (February 2026) Selection by Rheinmetall for Skyranger 30 air defense system
  • (2023-2024) Revenue scaled to €210-€220m driven by defense and medical segment expansion

Open the full interactive Lumibird SA report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →